Journey Medical Corporation (DERM)
NCM – Real Time Price. Currency in USD
4.58
-0.20 (-4.29%)
At close: Mar 27, 2026, 4:00 PM EDT
4.77
+0.20 (4.36%)
After-hours: Mar 27, 2026, 7:15 PM EDT

NCM – Real Time Price. Currency in USD
4.58
-0.20 (-4.29%)
At close: Mar 27, 2026, 4:00 PM EDT
4.77
+0.20 (4.36%)
After-hours: Mar 27, 2026, 7:15 PM EDT
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company’s marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Emrosi for the treatment of inflammatory lesions of rosacea, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
| Name | Position |
|---|---|
| Dr. Lindsay Allan Rosenwald M.D. | Executive Chairman |
| Jaclyn Jaffe | Senior Director of Corporate Operations |
| Mr. Claude Maraoui | Founder, President, CEO & Director |
| Mr. Joseph M. Benesch | CFO & Corporate Controller |
| Mr. Louis Donati | Director of Market Access |
| Mr. Ramsey Alloush | COO, General Counsel & Company Secretary |
| Mr. Robert Nevin | Chief Commercial Officer |
| Date | Type | Document |
|---|---|---|
| 2026-01-15 | S-3 | tm2534369d2_s3.htm |
| 2025-12-30 | DRS | filename1.htm |
| 2025-11-12 | 10-Q | derm-20250930x10q.htm |
| 2025-09-26 | 8-K | tm2527082d1_8k.htm |
| 2025-08-28 | 8-K | tm2524202d2_8kseq1.htm |
| 2025-08-12 | 10-Q | derm-20250630x10q.htm |
| 2025-07-14 | 8-K | tm2520913d1_8k.htm |
| 2025-06-26 | 8-K | tm2519010d1_8k.htm |
| 2025-06-24 | 8-K | tm2518699d1_8k.htm |
| 2025-05-15 | 10-Q | derm-20250331x10q.htm |